EP Wealth Advisors LLC purchased a new position in shares of Maximus, Inc. (NYSE:MMS – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,892 shares of the health services provider’s stock, valued at approximately $269,000.
Several other hedge funds and other institutional investors have also modified their holdings of MMS. V Square Quantitative Management LLC acquired a new position in Maximus during the 3rd quarter worth about $25,000. Blue Trust Inc. lifted its position in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after purchasing an additional 262 shares in the last quarter. Archer Investment Corp lifted its position in shares of Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Maximus by 150.6% in the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 518 shares during the period. Finally, Ariadne Wealth Management LP acquired a new position in shares of Maximus in the second quarter valued at approximately $90,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.
Insider Transactions at Maximus
In other Maximus news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Raymond B. Ruddy purchased 3,490 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the completion of the acquisition, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.40% of the company’s stock.
Maximus Trading Down 1.2 %
NYSE:MMS opened at $69.85 on Friday. Maximus, Inc. has a 12-month low of $69.72 and a 12-month high of $93.97. The firm has a market cap of $4.21 billion, a PE ratio of 13.97 and a beta of 0.73. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock has a fifty day moving average price of $82.58 and a 200 day moving average price of $86.59.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend was Friday, November 15th. Maximus’s payout ratio is presently 24.00%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- Bank Stocks – Best Bank Stocks to Invest In
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Expert Stock Trading Psychology Tips
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Are Dividend Achievers? An Introduction
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.